ATE132269T1 - Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen - Google Patents

Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen

Info

Publication number
ATE132269T1
ATE132269T1 AT92901813T AT92901813T ATE132269T1 AT E132269 T1 ATE132269 T1 AT E132269T1 AT 92901813 T AT92901813 T AT 92901813T AT 92901813 T AT92901813 T AT 92901813T AT E132269 T1 ATE132269 T1 AT E132269T1
Authority
AT
Austria
Prior art keywords
pain
peripheral nerve
nerve damage
diagnosing
low back
Prior art date
Application number
AT92901813T
Other languages
English (en)
Inventor
Bruce M Cameron Sr
Carl R Merril
Guy Joseph Creed
Dale Vanderputten
Original Assignee
Monoclonetics Int
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monoclonetics Int, Us Health filed Critical Monoclonetics Int
Application granted granted Critical
Publication of ATE132269T1 publication Critical patent/ATE132269T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Electrochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT92901813T 1990-11-30 1991-11-15 Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen ATE132269T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62010490A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
ATE132269T1 true ATE132269T1 (de) 1996-01-15

Family

ID=24484596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901813T ATE132269T1 (de) 1990-11-30 1991-11-15 Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen

Country Status (11)

Country Link
US (2) US5364793A (de)
EP (1) EP0559795B1 (de)
JP (1) JPH06503418A (de)
AT (1) ATE132269T1 (de)
AU (1) AU667462B2 (de)
CA (1) CA2097426A1 (de)
DE (1) DE69115926T2 (de)
DK (1) DK0559795T3 (de)
ES (1) ES2083152T3 (de)
GR (1) GR3018546T3 (de)
WO (1) WO1992010760A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK145393D0 (da) * 1993-12-23 1993-12-23 Stig Haunsoe Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
GB9509410D0 (en) * 1995-05-10 1995-07-05 Imperial College Molecular imaging
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
US6048691A (en) * 1996-05-13 2000-04-11 Motorola, Inc. Method and system for performing a binding assay
AUPO403496A0 (en) * 1996-12-05 1997-01-02 Macquarie Research Limited Electrophoresis separation methods
US5908383A (en) * 1997-09-17 1999-06-01 Brynjestad; Ulf Knowledge-based expert interactive system for pain
US6251587B1 (en) 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
GB9812290D0 (en) * 1998-06-09 1998-08-05 Univ Nottingham Back pain diagnosis
DE69932180T2 (de) 1998-11-23 2007-06-14 Proteome Sciences, Inc., Houston Verfahren und zusammensetzungen zur schmerzbehandlung
AU773329B2 (en) * 1999-05-14 2004-05-20 Proteomedica Ab Materials and methods relating to disease diagnosis
US6231525B1 (en) 1999-10-25 2001-05-15 William C. Paske System and method for providing quantified hand analysis
US6264621B1 (en) 1999-10-29 2001-07-24 William C. Paske System and method for providing quantified and qualitative hand analysis
ES2252263T3 (es) * 2000-07-25 2006-05-16 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Bacteriofago que tiene una gama de hospedadores multiple.
US7179609B1 (en) 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis
US20030113808A1 (en) * 2001-12-13 2003-06-19 George Jackowski Apolipoprotein biopolymer markers predictive of alzheimers disease
US20040097838A1 (en) * 2002-11-19 2004-05-20 Paske William C. System and apparatus for providing quantified hand analysis
US20040215074A1 (en) * 2003-04-24 2004-10-28 Vincenzo Giuliano Imaging and scoring method for cervical spinal impairment using magnetic resonance imaging
US7846094B2 (en) * 2004-03-17 2010-12-07 Miller Landon C G System and method for neurological injury detection, classification and subsequent injury amelioration
JP5537775B2 (ja) * 2005-01-28 2014-07-02 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア 細胞組織の痛み及び変性特性を評価するために核磁気共鳴（ｎｍｒ）分光を用いるシステム及び方法
US20080015465A1 (en) * 2006-06-15 2008-01-17 Scuderi Gaetano J Methods for diagnosing and treating pain in the spinal cord
US7709215B2 (en) * 2007-06-01 2010-05-04 Cytonics Corporation Method for diagnosing and treating acute joint injury
US8825131B2 (en) 2009-10-14 2014-09-02 Nocimed, Llc MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs
US8761860B2 (en) 2009-10-14 2014-06-24 Nocimed, Llc MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs
US9280718B2 (en) 2010-11-24 2016-03-08 Nocimed, Llc Systems and methods for automated voxelation of regions of interest for magnetic resonance spectroscopy
US11305023B2 (en) 2011-11-11 2022-04-19 Sam Popinchalk Method for diagnostically imaging lesions in the peripheral nervous system
US8965094B2 (en) 2012-04-14 2015-02-24 Nocimed, Llc Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method
WO2017120298A1 (en) * 2016-01-05 2017-07-13 University Of Rochester Treatment of radiculopathies with 4-aminopyridine or derivatives thereof
EP4289347B1 (de) 2016-06-19 2026-02-04 Aclarion, Inc. Magnetresonanz-spektroskopiesystem und verfahren zur diagnose von schmerz oder infektionen im zusammenhang mit propionsäure
AU2019264996A1 (en) * 2018-05-10 2020-11-26 The Methodist Hospital Methods for prognosis and management of disease

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1598807A1 (de) * 1966-07-16 1971-01-07 Merck Patent Gmbh Verfahren und Mittel zur Fruehdiagnose der Phenylketonurie,der Ahornsirupkrankheit und der Hypervalinaemie
AT320865B (de) * 1973-02-12 1975-03-10 Immuno Ag Verfahren zum Bestimmen von normalen und pathologischen Plasma-Lipoproteinen in menschlichen Körperflüssigkeiten und Apparat zur Durchführung des Verfahrens
US3979507A (en) * 1973-11-23 1976-09-07 Wilson Pharmaceutical & Chemical Corporation Diagnostic system for organ abnormalities
DE2406959C3 (de) * 1974-02-14 1979-02-08 Behringwerke Ag, 3550 Marburg Anordnung und Verfahren zur Bestimmung von Antigenen
US4124470A (en) * 1974-04-30 1978-11-07 Harald Dahms Method and apparatus for electrophoresis
US4118469A (en) * 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
NL7701800A (nl) * 1977-02-18 1978-08-22 Akzo Nv Testkit en methode voor de bepaling van lp-x.
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
DE2829531A1 (de) * 1978-07-05 1980-01-24 Heuck Claus Christian Dr Rer N Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4264589A (en) * 1978-12-20 1981-04-28 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
US4416998A (en) * 1981-04-02 1983-11-22 The Upjohn Company Silver stain procedure and kit for same
US4603106A (en) * 1982-02-22 1986-07-29 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
US4822776A (en) * 1981-09-08 1989-04-18 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
EP0180720B1 (de) * 1981-09-10 1990-06-13 B. Braun-SSC AG Vorrichtung zur selektiven extrakorporalen Präzipation von Low Density Lipoprotenen aus Vollserum oder Plasma
JPS58134992A (ja) * 1982-01-21 1983-08-11 Kitasato Inst:The 抗生物質ａｍ−２６０４−ａおよびその製造方法
US4468466A (en) * 1982-02-16 1984-08-28 The United States Of America As Represented By The Department Of Health And Human Services Silver stains for protein in gels--a modified procedure
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
FR2533704B1 (fr) * 1982-09-27 1986-03-21 Spiral Dosage immunologique dans le serum de l'apolipoproteine b des lipoproteines de basse densite
US4466951A (en) * 1982-11-12 1984-08-21 University Of California Intracellular trapping of therapeutics or tracer agents
DE3310727A1 (de) * 1983-03-24 1984-10-04 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven, extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile
US4558007A (en) * 1983-06-17 1985-12-10 Health Research, Inc. (Roswell Park Divison) Process for detecting LDHk isozyme activity in human serum for use as a diagnostic aid and for monitoring response to cancer therapy
US4654301A (en) * 1983-06-17 1987-03-31 Health Research, Inc. (Roswell Park Division) Process for detecting LDHk isozyme activity in human serum for use as a diagnostic aid and for monitoring response to cancer therapy
DE3323949A1 (de) * 1983-07-02 1985-01-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
JPS61500053A (ja) * 1983-09-30 1986-01-16 マサチユ−セツツ　インステイチユ−ト　オブ　テクノロジ− Ａ肝炎ウィルス配列順を表すｃＤＮＡの生成
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
FR2560996B1 (fr) * 1984-03-09 1988-01-15 Commissariat Energie Atomique Procede de dosage immunologique d'antigenes, d'anticorps ou d'haptenes, son utilisation pour le dosage des lipoproteines et de l'a-foetoproteine et trousses de dosage pour la mise en oeuvre de ce procede
US4619895A (en) * 1984-05-10 1986-10-28 The Regents Of The University Of California Lipoprotein marker for hypertriglyceridemia
US4978503A (en) * 1984-06-13 1990-12-18 Ares-Serono Research & Development Limited Partnership Devices for use in chemical test procedures
JPH06105257B2 (ja) * 1984-08-07 1994-12-21 協和メデックス株式会社 癌の測定用キット
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
JPH065227B2 (ja) * 1985-02-27 1994-01-19 オリンパス光学工業株式会社 電気泳動装置による総蛋白値の定量方法
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US4895558A (en) * 1985-07-15 1990-01-23 University Of Queensland Autologous plasma delipidation using a continuous flow system
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
SE448324B (sv) * 1985-09-27 1987-02-09 Pharmacia Ab Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner
US4772549A (en) * 1986-05-30 1988-09-20 Biotechnology Research Partners, Ltd. Polymorphisms related to lipid metabolism: ApoB, ApoCII, ApoE, ApoAIV
US4943527A (en) * 1985-10-04 1990-07-24 California Biotechnology Inc. Mature apoai protein production under serum free culturing conditions
US5049488A (en) * 1985-11-08 1991-09-17 Genentech, Inc. Method and nucleic acid for the preparation of lecithin:cholesterol acyltransferase
US4973638A (en) * 1986-04-30 1990-11-27 Southwest Foundation For Biomedical Researche Polyamide resin and method for preparation of reagents for immunodiagnostic use
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4948723A (en) * 1987-01-16 1990-08-14 Bioscience International, Inc. Method of diagnosis and severity-assessment of pancreatic disease
US4792621A (en) * 1986-07-28 1988-12-20 Amoco Corporation Method for continuous production of aromatic carboxylic acid
US4828986A (en) * 1986-09-29 1989-05-09 Scripps Clinic And Research Foundation Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
JPH0667948B2 (ja) * 1986-12-23 1994-08-31 花王株式会社 抗生物質ｙｉ−ｈｕ３及びその製造法
US4935363A (en) * 1987-03-30 1990-06-19 Board Of Regents, The University Of Texas System Sterol regulatory elements
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias
GB8717791D0 (en) * 1987-07-28 1987-09-03 Baralle F E Immunoassay method
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
US4945040A (en) * 1988-02-29 1990-07-31 Arch Development Corporation Immunoassay for lipoprotein(a)
US5030722A (en) * 1988-03-30 1991-07-09 The Johns Hopkins University Odorant-binding protein from rat
AU4511189A (en) * 1988-10-25 1990-05-14 Invitron Corporation Specific removal of ldl from blood
US4975528A (en) * 1989-04-07 1990-12-04 Affinity Biotech, Inc. Process for separation and concentration of apolipoproteins using perfluorocarbon emulsion
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
US5045480A (en) * 1989-02-09 1991-09-03 Miles Inc. Gel particles having hapten moieties bound thereto as immunoassay reagent
SE8901127D0 (sv) * 1989-03-31 1989-03-31 Aa H L Pousette Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
US5187068A (en) * 1989-06-09 1993-02-16 Nicolae Luca Method for determination of lipid moiety and apolipoprotein expressed epitope immunoreactivity on intact lipoprotein

Also Published As

Publication number Publication date
EP0559795B1 (de) 1995-12-27
US5364793A (en) 1994-11-15
ES2083152T3 (es) 1996-04-01
GR3018546T3 (en) 1996-03-31
US5583201A (en) 1996-12-10
WO1992010760A1 (en) 1992-06-25
JPH06503418A (ja) 1994-04-14
DE69115926D1 (de) 1996-02-08
DE69115926T2 (de) 1996-05-30
CA2097426A1 (en) 1992-05-31
EP0559795A1 (de) 1993-09-15
AU667462B2 (en) 1996-03-28
DK0559795T3 (da) 1996-01-29
AU9116991A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
DE69115926D1 (de) Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
ATE157123T1 (de) Verfahren und vorrichtung zur amperometrischen diagnostischen analyse
ATE137583T1 (de) Verfahren und vorrichtung zur bestimmung von chemischen spezies in körperflüssigkeit
ATE117800T1 (de) Vorrichtung und verfahren zur bestimmung eines bestandteiles in einer flüssigkeitsprobe.
CA2373860A1 (en) Method and apparatus for non-invasive blood analyte measurement
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
HU9202178D0 (en) Method for detecting irregularities of bone and other connective tissues in human beings and in animals
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
DE69014201D1 (de) Verfahren und testsatz zur bestimmung von tyrosinphosphorylierungs- und dephosphorylierungsaktivitäten.
DE69505376D1 (de) Alpha b crystallin zur verwendung in diagnose und therapie von autoimmunkrankheiten, besonders multipler skerose
ES8504218A1 (es) Sistema de diagnostico de parasitosis y alergias
DE68920477D1 (de) Verfahren zur Diagnose von Tumoren.
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
Hutchinson et al. Visual evoked responses and immunoglobulin abnormalities in the diagnosis of multiple sclerosis
ATE196688T1 (de) Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren
Alam et al. Free sialic acid levels in the cerebrospinal fluid of patients with meningitis.
Cooper Identification of the Serum Fraction Carrying Syphilitic Reagin by Electrophoresis.
DE59812128D1 (de) Diagnosekit für hauttest und verfahren zur durchführung desselben
Casey et al. The electrophoretic demonstration of unique oligoclonal immunoglobulins in cerebrospinal fluid as a diagnostic test for multiple sclerosis
ATE139031T1 (de) Verfahren und vorrichtung zur feststellung des reaktionsgrades zwischen einem fremdkörper und den blutzellen eines patienten
Löwhagen et al. Central nervous system involvement in early syphilis. Part II. Correlation between auditory brain stem responses (ABR) and cerebrospinal fluid abnormalities
Milne et al. Gamma-glutamyl transpeptidase and its multiple forms in the tissues and sera of normal dogs
Sultanov et al. Determination of Staphylococcus toxin in blood with immobilized antibodies on polyamide carrier.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee